Thermo Fisher brings TaqPath respiratory viral select panel

Thermo Fisher Scientific has launched Applied Biosystems TaqPath

Respiratory Viral Select Panel; a CEIVD-marked molecular assay panel for the detection of five common viruses, including those that cause the common cold, bronchiolitis, croup, influenzalike illnesses, and pneumonia. The molecular assay panel provides results in approximately three hours, testing for Adenovirus, Human Metapneumovirus, Rhinovirus/Enterovirus, and Parainfluenza virus, using highly accurate PCR technology. RNase P and positive controls are included to offer sample-to-result reliability. The solution is scalable, which allows laboratories to run from one to 94 samples simultaneously depending on the needs of the population they’re servicing and can help to identify co-infections. The TaqPath Respiratory Viral Select Panel is for In Vitro Diagnostic Use and is only available in select EMEA countries.